Literature DB >> 11568030

Regression of left ventricular hypertrophy after surgical therapy for aortic stenosis is associated with changes in extracellular matrix gene expression.

T Walther1, A Schubert, V Falk, C Binner, A Kanev, S Bleiziffer, C Walther, N Doll, R Autschbach, F W Mohr.   

Abstract

BACKGROUND: Regression of left ventricular hypertrophy (LVH) after surgical correction for aortic stenosis is not fully understood on the molecular level. The aim of this study was to examine whether there is an association between LVH regression and extracellular matrix (ECM) gene expression. METHODS AND
RESULTS: A standard model of controlled LVH induction by supracoronary banding (A=baseline) was applied in 44 growing sheep (age, 6 to 8 months). Surgical correction to release the pressure gradient was performed 8.3+/-1 months later (B). The animals were killed after another 10.1+/-2 months (C). At all time points, hemodynamic evaluations and quantitative analysis of mRNA and protein expression for matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) was performed. Left ventricular mass index was 82+/-21 (A) versus 150+/-33 (B), P<0.01, and 78+/-18 g/m(2) (C), P<0.01. Left ventricular function and cardiac index remained stable. Myocardial fiber diameter index was 9.1+/-1.2 (A) versus 12.3+/-1.4 (B), P<0.01, and 8.4+/-1.3 micrometer/m(2) (C), P<0.01. In parallel to the development of LVH at B, gene expression was increased significantly for MMP-1, MMP-2, MMP-3, and MMP-9 and for TIMP-1 and TIMP-2 and decreased significantly for TIMP-3. After surgical correction (C), there was a complete regression of gene expression to baseline measures.
CONCLUSIONS: Controlled induction of compensated LVH leads to significant increase in ECM gene expression. The regression of LVH after surgical therapy is associated with complete regression of ECM gene expression. However, no cause-and-effect relation could be demonstrated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11568030     DOI: 10.1161/hc37t1.094777

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Progressive induction of left ventricular pressure overload in a large animal model elicits myocardial remodeling and a unique matrix signature.

Authors:  William M Yarbrough; Rupak Mukherjee; Robert E Stroud; William T Rivers; J Marshall Oelsen; Jennifer A Dixon; Shaina R Eckhouse; John S Ikonomidis; Michael R Zile; Francis G Spinale
Journal:  J Thorac Cardiovasc Surg       Date:  2011-11-04       Impact factor: 5.209

Review 2.  Myocardial remodeling with aortic stenosis and after aortic valve replacement: mechanisms and future prognostic implications.

Authors:  William M Yarbrough; Rupak Mukherjee; John S Ikonomidis; Michael R Zile; Francis G Spinale
Journal:  J Thorac Cardiovasc Surg       Date:  2011-07-16       Impact factor: 5.209

3.  Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis.

Authors:  Jens Fielitz; Manuela Leuschner; Heinz Renee Zurbrügg; Britta Hannack; Reinhard Pregla; Roland Hetzer; Vera Regitz-Zagrosek
Journal:  J Mol Med (Berl)       Date:  2004-11-19       Impact factor: 4.599

4.  Circulating matrix metalloproteinase patterns in association with aortic dilatation in bicuspid aortic valve patients with isolated severe aortic stenosis.

Authors:  Yongshi Wang; Boting Wu; Lili Dong; Chunsheng Wang; Xiaolin Wang; Xianhong Shu
Journal:  Heart Vessels       Date:  2014-10-18       Impact factor: 2.037

5.  Cardiac-restricted overexpression or deletion of tissue inhibitor of matrix metalloproteinase-4: differential effects on left ventricular structure and function following pressure overload-induced hypertrophy.

Authors:  William M Yarbrough; Catalin Baicu; Rupak Mukherjee; An Van Laer; William T Rivers; Richard A McKinney; Corey B Prescott; Robert E Stroud; Parker D Freels; Kia N Zellars; Michael R Zile; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-03       Impact factor: 4.733

6.  Circulating stromelysin-1 (MMP-3): a novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction.

Authors:  D Kelly; S Khan; G Cockerill; L L Ng; M Thompson; N J Samani; I B Squire
Journal:  Eur J Heart Fail       Date:  2008-01-30       Impact factor: 15.534

7.  Tissue inhibitor of matrix metalloproteinase-3 or vascular endothelial growth factor transfection of aged human mesenchymal stem cells enhances cell therapy after myocardial infarction.

Authors:  Jie Yao; Shu-Lin Jiang; Wei Liu; Cheng Liu; Wei Chen; Lu Sun; Kai-Yu Liu; Zhi-Bo Jia; Ren-Ke Li; Hai Tian
Journal:  Rejuvenation Res       Date:  2012-09-24       Impact factor: 4.663

8.  Muscle ring finger 1 mediates cardiac atrophy in vivo.

Authors:  Monte S Willis; Mauricio Rojas; Luge Li; Craig H Selzman; Ru-Hang Tang; William E Stansfield; Jessica E Rodriguez; David J Glass; Cam Patterson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-23       Impact factor: 4.733

Review 9.  Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?

Authors:  Mark Sweeney; Ben Corden; Stuart A Cook
Journal:  EMBO Mol Med       Date:  2020-09-21       Impact factor: 12.137

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.